Literature DB >> 7337928

Antitumor activity of acylated oridonin.

E Fujita, Y Nagao, T Kohno, M Matsuda, M Ozaki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7337928     DOI: 10.1248/cpb.29.3208

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  7 in total

1.  Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis.

Authors:  Chunyong Ding; Yusong Zhang; Haijun Chen; Zhengduo Yang; Christopher Wild; Na Ye; Corbin D Ester; Ailian Xiong; Mark A White; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2013-10-31       Impact factor: 7.446

2.  Effect of oridonin, a Rabdosia diterpenoid, on radiosensitization with misonidazole.

Authors:  C Murayama; Y Nagao; S Sano; M Ochiai; K Fuji; E Fujita; T Mori
Journal:  Experientia       Date:  1987-12-01

3.  Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position.

Authors:  Chunyong Ding; Yusong Zhang; Haijun Chen; Christopher Wild; Tianzhi Wang; Mark A White; Qiang Shen; Jia Zhou
Journal:  Org Lett       Date:  2013-07-08       Impact factor: 6.005

4.  Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility.

Authors:  Chunyong Ding; Yusong Zhang; Haijun Chen; Zhengduo Yang; Christopher Wild; Lili Chu; Huiling Liu; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2013-06-19       Impact factor: 7.446

5.  Structural modification of oridonin via DAST induced rearrangement.

Authors:  Dong-Dong Luo; Kai Peng; Jia-Yu Yang; Pawinee Piyachaturawat; Witchuda Saengsawang; Lei Ao; Wan-Zhou Zhao; Yu Tang; Sheng-Biao Wan
Journal:  RSC Adv       Date:  2018-08-20       Impact factor: 4.036

6.  Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway.

Authors:  Hua Liu; Changlin Qian; Zhiyong Shen
Journal:  Tumour Biol       Date:  2014-06-12

Review 7.  Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound.

Authors:  Dahong Li; Tong Han; Jie Liao; Xu Hu; Shengtao Xu; Kangtao Tian; Xiaoke Gu; Keguang Cheng; Zhanlin Li; Huiming Hua; Jinyi Xu
Journal:  Int J Mol Sci       Date:  2016-08-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.